Search research articles
Contact Us
Filters
Showing results (131-140 of 163) with videos related to
Page
of 17
Sort By:
Journal of Drugs in Dermatology : JDD
|
January 11, 2018
Pivotal Trial of the Efficacy and Safety of Oxymetazoline Cream 1.0% for the Treatment of Persistent Facial Erythema Associated With Rosacea: Findings from the First REVEAL Trial
Leon H Kircik, Janet DuBois, Zoe Diana Draelos, et al.
Dermatology and Therapy
|
July 8, 2021
The Proposed PASI-HD Provides More Precise Assessment of Plaque Psoriasis Severity in Anatomical Regions with a Low Area Score
Kim A Papp, Mark G Lebwohl, Leon H Kircik, et al.
Pediatric Dermatology
|
July 9, 2010
Re: Propranolol treatment for hemangioma of infancy: risks and recommendations
Susan J Bayliss, David R Berk, George F Van Hare, et al.
The Journal of Clinical and Aesthetic Dermatology
|
November 17, 2016
Efficacy, Safety, and Dermal Tolerability of Dapsone Gel, 7.5% in Patients with Moderate Acne Vulgaris: A Pooled Analysis of Two Phase 3 Trials
Diane M Thiboutot, Leon Kircik, Amy McMichael, et al.
Pediatric Dermatology
|
April 22, 2011
Acanthosis nigricans and hypochondroplasia in a child with a K650Q mutation in FGFR3
David R Berk, Maria Del Carmen Boente, Daniela Montanari, et al.
Journal of Cardiopulmonary Rehabilitation and Prevention
|
November 1, 2016
Multicenter Study of Temporal Trends in the Achievement of Atherosclerotic Cardiovascular Disease Risk Factor Goals During Cardiac Rehabilitation
Neil F Gordon, Richard D Salmon, Laurence S Sperling, et al.
Journal of Drugs in Dermatology : JDD
|
July 8, 2017
Treatment Response With Once-Daily Topical Dapsone Gel, 7.5% for Acne Vulgaris: Subgroup Analysis of Pooled Data from Two Randomized, Double-Blind Stu
Zoe Diana Draelos, David A Rodriguez, Steven E Kempers, et al.
American Journal of Human Genetics
|
August 28, 2012
Genomic profiling of a human organotypic model of AEC syndrome reveals ZNF750 as an essential downstream target of mutant TP63
Brian J Zarnegar, Dan E Webster, Vanessa Lopez-Pajares, et al.
Circulation
|
August 1, 1993
Can further benefit be achieved by adding flosequinan to patients with congestive heart failure who remain symptomatic on diuretic, digoxin, and an angiotensin converting enzyme inhibitor? Results of the flosequinan-ACE inhibitor trial (FACET)
B M Massie, M R Berk, S C Brozena, et al.
Journal of the American Academy of Dermatology
|
February 8, 2018
Efficacy and safety of oxymetazoline cream 1.0% for treatment of persistent facial erythema associated with rosacea: Findings from the 52-week open label REVEAL trial
Zoe Diana Draelos, Michael H Gold, Robert A Weiss, et al.
Page
of 17
Search research articles
Search
Showing results (131-140 of 163) with videos related to
Sort By:
Page
of 17
Journal of Drugs in Dermatology : JDD
|
January 11, 2018
Pivotal Trial of the Efficacy and Safety of Oxymetazoline Cream 1.0% for the Treatment of Persistent Facial Erythema Associated With Rosacea: Findings from the First REVEAL Trial
Leon H Kircik, Janet DuBois, Zoe Diana Draelos, et al.
Dermatology and Therapy
|
July 8, 2021
The Proposed PASI-HD Provides More Precise Assessment of Plaque Psoriasis Severity in Anatomical Regions with a Low Area Score
Kim A Papp, Mark G Lebwohl, Leon H Kircik, et al.
Pediatric Dermatology
|
July 9, 2010
Re: Propranolol treatment for hemangioma of infancy: risks and recommendations
Susan J Bayliss, David R Berk, George F Van Hare, et al.
The Journal of Clinical and Aesthetic Dermatology
|
November 17, 2016
Efficacy, Safety, and Dermal Tolerability of Dapsone Gel, 7.5% in Patients with Moderate Acne Vulgaris: A Pooled Analysis of Two Phase 3 Trials
Diane M Thiboutot, Leon Kircik, Amy McMichael, et al.
Pediatric Dermatology
|
April 22, 2011
Acanthosis nigricans and hypochondroplasia in a child with a K650Q mutation in FGFR3
David R Berk, Maria Del Carmen Boente, Daniela Montanari, et al.
Journal of Cardiopulmonary Rehabilitation and Prevention
|
November 1, 2016
Multicenter Study of Temporal Trends in the Achievement of Atherosclerotic Cardiovascular Disease Risk Factor Goals During Cardiac Rehabilitation
Neil F Gordon, Richard D Salmon, Laurence S Sperling, et al.
Journal of Drugs in Dermatology : JDD
|
July 8, 2017
Treatment Response With Once-Daily Topical Dapsone Gel, 7.5% for Acne Vulgaris: Subgroup Analysis of Pooled Data from Two Randomized, Double-Blind Stu
Zoe Diana Draelos, David A Rodriguez, Steven E Kempers, et al.
American Journal of Human Genetics
|
August 28, 2012
Genomic profiling of a human organotypic model of AEC syndrome reveals ZNF750 as an essential downstream target of mutant TP63
Brian J Zarnegar, Dan E Webster, Vanessa Lopez-Pajares, et al.
Circulation
|
August 1, 1993
Can further benefit be achieved by adding flosequinan to patients with congestive heart failure who remain symptomatic on diuretic, digoxin, and an angiotensin converting enzyme inhibitor? Results of the flosequinan-ACE inhibitor trial (FACET)
B M Massie, M R Berk, S C Brozena, et al.
Journal of the American Academy of Dermatology
|
February 8, 2018
Efficacy and safety of oxymetazoline cream 1.0% for treatment of persistent facial erythema associated with rosacea: Findings from the 52-week open label REVEAL trial
Zoe Diana Draelos, Michael H Gold, Robert A Weiss, et al.
Page
of 17